Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/83509
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorProud, C.-
dc.date.issued2009-
dc.identifier.citationJournal of Molecular Cell Biology, 2009; 1(2):61-63-
dc.identifier.issn1674-2788-
dc.identifier.issn1759-4685-
dc.identifier.urihttp://hdl.handle.net/2440/83509-
dc.description.abstractThe mammalian target of rapamycin, mTOR, is a key node in cellular regulation: its dysregulation is important in a number of disease states, including various cancers. A recent study identifies a new partner and regulator of mTOR, which can alter the balance of signaling downstream of mTOR and appears to be important in certain cancers, such as multiple myelomas.-
dc.description.statementofresponsibilityChristopher G. Proud-
dc.language.isoen-
dc.publisherOxford University Press-
dc.rights© The Author (2009).-
dc.source.urihttp://dx.doi.org/10.1093/jmcb/mjp012-
dc.subjectAnimals-
dc.subjectHumans-
dc.subjectMultiple Myeloma-
dc.subjectIntracellular Signaling Peptides and Proteins-
dc.subjectCarrier Proteins-
dc.subjectSignal Transduction-
dc.subjectEnzyme Activation-
dc.subjectProtein Binding-
dc.subjectModels, Biological-
dc.subjectProto-Oncogene Proteins c-akt-
dc.subjectTOR Serine-Threonine Kinases-
dc.subjectProtein Serine-Threonine Kinases-
dc.titleDynamic balancing: Deptor tips the scales-
dc.typeJournal article-
dc.identifier.doi10.1093/jmcb/mjp012-
pubs.publication-statusPublished-
dc.identifier.orcidProud, C. [0000-0003-0704-6442]-
Appears in Collections:Aurora harvest
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.